Jo Chien

10PUBLICATIONS
76CO-AUTHORS
Tumour immunologyMolecular targetsPredictive and prognostic markersCounselling psychologyObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 17, 2025
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial.

Denise M Wolf, Christina Yau, Michael Campbell

|Dec 18, 2023
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.

Kathy S Albain, Christina Yau, Emanuel F Petricoin

|Oct 13, 2023
The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database (NCDB).

Harriet T Rothschild, Elle N Clelland, Mary Kathryn Abel

|Jul 27, 2023
Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes.

Elle N Clelland, Harriet T Rothschild, Anne Patterson

|Apr 05, 2023
HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series.

Harriet T Rothschild, Elle Clelland, Anne Patterson

|Feb 25, 2022
Evaluation of the Pathways for Survivors Program to Address Breast Cancer Survivorship-Associated Distress: Survey Study.

Saumya Umashankar, Matina Elise Mamounas, Madeline Matthys

Pageof 2

Frequent Collaborators

4 joint publications

W Fraser Symmans

4 joint publications

Laura J Esserman

3 joint publications

Hope S Rugo

3 joint publications

Harriet T Rothschild